Back to Search Start Over

Risks of Recurrent Cardiovascular Events and Mortality in 1-Year Survivors of Acute Myocardial Infarction Implanted with Newer-Generation Drug-Eluting Stents.

Authors :
Lim, Sungmin
Choo, Eun Ho
Choi, Ik Jun
Lee, Kwan Yong
Lee, Su Nam
Hwang, Byung-Hee
Kim, Chan Joon
Park, Mahn-Won
Lee, Jong-Min
Park, Chul Soo
Kim, Hee-Yeol
Yoo, Ki-Dong
Jeon, Doo Soo
Youn, Ho Joong
Chung, Wook Sung
Kim, Min Chul
Jeong, Myung Ho
Yim, Hyeon Woo
Ahn, Youngkeun
Chang, Kiyuk
Source :
Journal of Clinical Medicine. Aug2021, Vol. 10 Issue 16, p3642-3642. 1p.
Publication Year :
2021

Abstract

Current treatments for acute myocardial infarction (AMI) have dramatically improved clinical outcomes during the first year after AMI. Less is known, however, about the subsequent risks of recurrent cardiovascular events and mortality in patients who survive 1 year after AMI. The purpose of the present study is to evaluate long-term clinical outcomes in 1-year AMI survivors who were implanted with newer-generation drug-eluting stents (DESs) since 2010. The COREA-AMI (CardiOvascular Risk and idEntificAtion of potential high-risk population in AMI) registry consecutively enrolled AMI patients who underwent percutaneous coronary intervention (PCI), and patients who received newer-generation DESs since 2010 were analyzed. The primary endpoint was major adverse cardiovascular events (MACEs), and secondary endpoint was all-cause mortality. Of 6242 AMI patients, 5397 were alive 1 year after the index procedure. The cumulative incidence of MACEs and all-cause death 1 to 7 years after AMI were 28.4% (annually 4–6%) and 20.2% (annually 3–4%), respectively. Multivariate analysis showed that uncontrolled systolic blood pressure (SBP) and serum low-density lipoprotein cholesterol (LDL-C) concentration, as well as traditional risk factors, were associated with MACEs and all-cause death. Recurrent non-fatal myocardial infarction, ischemic stroke, and bleeding events within 1 year were significantly associated with all-cause death. The risks of adverse cardiovascular events and death remain high in AMI patients more than 1 year after the index PCI with newer-generation DESs. Traditional risk factors, uncontrolled SBP and LDL-C, and non-fatal adverse events within 1 year after the index procedure strongly influence long-term clinical outcomes. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
20770383
Volume :
10
Issue :
16
Database :
Academic Search Index
Journal :
Journal of Clinical Medicine
Publication Type :
Academic Journal
Accession number :
152147823
Full Text :
https://doi.org/10.3390/jcm10163642